This compound is a pharmaceutical intermediate used in the synthesis of bilastine, a second-generation antihistamine. It features a sulfonate ester group and an oxazole ring, contributing to its role in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 202189-76-2
3-Chloro-4-(3-fluorobenzyloxy)aniline
pharmaceutical intermediate
L-Isocitric acid
pharmaceutical intermediate
4-Nitrothalidomide, (S)-
pharmaceutical intermediate
C-6-Cl-ddG
pharmaceutical intermediate
2-[4-[2-(4,4-dimethyl-5H-1,3-oxazol-2-yl)propan-2-yl]phenyl]ethyl 4-methylbenzenesulfonate
BGUOPDZOVDIWLE-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)OCCC2=CC=C(C=C2)C(C)(C)C3=NC(CO3)(C)C